- $1 billion ATM equity program announced. Centrus Energy Corp. (NYSE American: LEU) filed an automatically effective shelf registration and a new at‑the‑market (“ATM”) program authorizing up to $1.0 billion in Class A common stock sales through a syndicate led by Barclays, Citigroup, UBS and Evercore ISI, among others. The prospectus supplement indicates agents earn a 1.5% commission on sales, and the prior 2024 ATM was terminated upon entry into the new Sales Agreement. Proceeds are for general corporate purposes, including technology investment, debt repayment, capex and potential acquisitions. SEC+2SEC+2
- Q3 2025 results mixed. For the quarter ended Sept. 30, 2025, Centrus reported revenue of $74.9M (+30% YoY) and net income of $3.9M (diluted EPS $0.19). Segment results: LEU revenue $44.8M and Technical Solutions $30.1M; the company posted a $4.3M gross loss as lower average prices for SWU offset uranium sales growth.
- Shares fall on the news. As of publication, LEU traded around $271.78, down ~16% intraday.
Centrus unveils $1B equity program to fund growth
Before the U.S. market open on Thursday, Centrus launched a $1 billion ATM equity program, enabling it to sell shares “from time to time” at prevailing market prices. According to the SEC‑filed prospectus supplement, the agent group includes Barclays, Citi, UBS, Evercore ISI, B. Riley, Guggenheim, MUFG, William Blair, Lake Street Capital Markets, and Northland; agent compensation is 1.5% of gross sales. The filing also notes Centrus terminated its prior 2024 ATM upon signing the new Sales Agreement. SEC
In its press release, the company said net proceeds may fund technology investment, debt repayment, capital expenditures, acquisitions, and other general corporate purposes—giving Centrus flexibility as it scales enrichment capacity and its HALEU program. The shares will be issued under an automatic shelf (Form S‑3ASR, File No. 333‑291305) that became effective today under Rule 462(e).
An accompanying Form 8‑K filed today details the Sales Agreement parties and confirms that Centrus has no obligation to sell any specific amount under the ATM, with the program expiring once the full amount is sold or earlier termination by the company/agents.
Third‑quarter 2025: revenue up, margins pressured
Centrus reported Q3 2025 revenue of $74.9 million (vs. $57.7 million a year ago) and net income of $3.9 million (diluted EPS $0.19), reflecting a stronger top line but a quarter of gross loss ($4.3M) due largely to lower average SWU pricing and product mix in the LEU segment. Segment detail from the company’s 10‑Q shows:
- LEU revenue $44.8M; cost of sales $52.6M; gross loss $7.8M.
- Technical Solutions revenue $30.1M; cost of sales $26.6M; gross profit $3.5M.
Management attributed the Technical Solutions revenue growth primarily to increased activity under the DOE HALEU Operation Contract; DOE also extended Phase 2 through Oct. 31, 2025 as negotiations continued to definitize portions of that work.
The company’s press release likewise highlighted the +31% Technical Solutions revenue increase and the quarter’s gross loss tied to LEU/SWU dynamics, aligning with details in the SEC filing.
Market reaction: LEU stock falls double‑digits
Centrus shares dropped sharply in Thursday trading following the ATM announcement and the mixed margin picture, recently changing hands near $271.78, down ~16% intraday. (Price updates in the live chart below.)
Why the raise now? HALEU, capacity and policy tailwinds
Centrus remains one of the few U.S. players positioned to supply high‑assay low‑enriched uranium (HALEU)—fuel enriched between 5% and 20%—needed for many advanced reactors. U.S. policy has been moving to onshore HALEU supply and reduce reliance on Russia; in Oct. 2024, the DOE awarded initial HALEU production contracts to multiple firms (including Centrus’s American Centrifuge Operating unit), a program that could reach $2.7 billion depending on appropriations.
On the operations front, Centrus has said it is planning a multi‑billion‑dollar expansion at its Piketon, Ohio facility, targeting at least 300 new operations jobs (hiring underway) and 1,000 construction jobs—contingent on federal funding decisions for LEU and HALEU. The company pitched the expansion alongside state and regional partners in late September.
Call notes & backlog (what we’re watching)
On this morning’s call, management discussed the quarterly results and order pipeline; third‑party call summaries indicate total company backlog around $3.9 billion spanning deliveries into 2040—a figure investors will watch as Centrus times potential ATM share sales against contract wins and funding milestones.
What today’s news means for investors
- Balance‑sheet flexibility: The ATM bolsters liquidity without forcing a single large, discounted deal. But it also introduces near‑term dilution risk if shares are sold while volatility is elevated.
- Execution on HALEU/LEU: Margin volatility—especially in SWU pricing—was on display this quarter. Securing and delivering higher‑margin HALEU volumes and advancing the Piketon expansion could help mix and scale effects over time.
- Policy catalyst path: DOE contracting and any Congressional appropriations tied to domestic HALEU build‑out remain key external drivers.
The bottom line
On Nov. 6, 2025, Centrus Energy (LEU) paired a $1B ATM launch with Q3 results that showed solid top‑line growth but pressured margins, sending the stock lower intraday. The raise gives Centrus optionality to fund HALEU and enrichment capacity at a moment when U.S. policy is pushing for domestic supply. Investors will be watching the pace of any ATM sales, DOE funding decisions, and signs that higher‑value HALEU output and long‑dated contracts can stabilize profitability.
Disclosure: This article is for informational purposes only and does not constitute investment advice.
